Hospital for Special Surgery Shoulder Arthroplasty Cohort

Part of paid clinical trials in New York, New York.

Sponsor
Hospital for Special Surgery, New York
Study ID
NCT00527839
Status
Recruiting
Apply to this trial

Conditions

  • Shoulder Arthroplasty

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes. HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here. The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.

Key Dates

Start date
Apr 30, 2007
Status verified
Nov 2025
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
250 participants (estimated)

Primary Outcome Measure

Patient Reported Outcome Measures (PROMs) [ Time Frame: Collection of at Baseline, 6 Months, 1 Year, 2 Year, 5 Year and 10 Year ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Hospital for Special SurgeryNew YorkNew York10021
Gina Aharonoff, MS
[email protected]
646-797-8904
Kaitlyn Lillemoe
[email protected]
Lisa Mandl, MD (SUB_INVESTIGATOR)
Thomas Sculco, MD (SUB_INVESTIGATOR)
Robert Marx, MD (PRINCIPAL_INVESTIGATOR)
Stephen Lyman, PhD (SUB_INVESTIGATOR)
Alvin Mushlin, MD,ScM (SUB_INVESTIGATOR)
Hassan Ghomrawi, PhD (SUB_INVESTIGATOR)
Stephen Incavo, MD (SUB_INVESTIGATOR)
John Rutledge (SUB_INVESTIGATOR)
Jason Guardado (SUB_INVESTIGATOR)
Madhu Mazumdar, PhD (SUB_INVESTIGATOR)
Stephen Goldring, MD (SUB_INVESTIGATOR)
Renee Razzano, MA (SUB_INVESTIGATOR)
Jo Hannafin, MD,PhD (SUB_INVESTIGATOR)
Gina Aharonoff (SUB_INVESTIGATOR)
Andrew Weiland, MD (SUB_INVESTIGATOR)
Answorth A Allen, MD (SUB_INVESTIGATOR)
David Altchek, MD (SUB_INVESTIGATOR)
Struan H Coleman, MD, PhD (SUB_INVESTIGATOR)
Frank Cordasco, MD (SUB_INVESTIGATOR)
Edward V Craig, MD (SUB_INVESTIGATOR)
David M Dines, MD (SUB_INVESTIGATOR)
Stephen Fealy, MD (SUB_INVESTIGATOR)
Anne Kelly, MD (SUB_INVESTIGATOR)
Bryan Kelly, MD (SUB_INVESTIGATOR)
John D MacGillivray, MD (SUB_INVESTIGATOR)
Michael Maynard, MD (SUB_INVESTIGATOR)
Stephen J O'Brien, MD (SUB_INVESTIGATOR)
Andrew D Pearle, MD (SUB_INVESTIGATOR)
Beth Shubin Stein, MD (SUB_INVESTIGATOR)
Scott Rodeo, MD (SUB_INVESTIGATOR)
Howard A Rose, MD (SUB_INVESTIGATOR)
Russell F Warren, MD (SUB_INVESTIGATOR)
Thomas L Wickiewicz, MD (SUB_INVESTIGATOR)
Riley J Williams, MD (SUB_INVESTIGATOR)
Kenneth Mathis, MD (SUB_INVESTIGATOR)
Nadia Camille (SUB_INVESTIGATOR)
Justine Shum (SUB_INVESTIGATOR)
Tamara Hagoel (SUB_INVESTIGATOR)
Daniel Fischer (SUB_INVESTIGATOR)
Kaitlyn Lillemoe (SUB_INVESTIGATOR)
Nam Giang (SUB_INVESTIGATOR)
Huong Do, MS (SUB_INVESTIGATOR)
Hospital for Special SurgeryNew YorkNew York10021
Gina Aharonoff
[email protected]
646-797-8904
Kaitlyn Lillemoe
[email protected]

Find similar trials in New York, NY

By research site
Hospital for Special Surgery· New York, NY

Related Studies